Online friends
Search Articles
Tag Cloud
- depression
- intro
- anxiety
- piracetam
- supplements
- nootropic
- aging
- longevity
- Hello
- noopept
- Dopamine
- modafinil
- brain
- cancer
- c60
- ADHD
- resveratrol
- stack
- 07-04-2015
- health
- choline
- 01-04-2015
- memory
- new
- Aniracetam
- nad+
- nmn
- sleep
- introduction
- diet
- Exercise
- brain fog
- mitochondria
- anhedonia
- ----
- rapamycin
- life extension
- pramiracetam
- oxiracetam
- phenibut
- serotonin
- Supplement
- stem cells
- GABA
- cryonics
- research
- brain health
- ssri
- alcar
- nootropics
Fight Aging News
-
Lasting Epigenetic Changes Results from DNA Double Strand Break Repair
Gene expression is the complex process of produci...
Yesterday, 07:08 PM Read Full Story -
A Sarcopenia-Related MicroRNA May Help Pinpoint Its Origin
In Aging Cell, researchers have discovered a pote...
Yesterday, 05:23 PM Read Full Story -
Mitochondrially Targeted Fluoropolymer Nanoparticle Induces Mitophagy to Improve Function
Finding molecules or nanoparticles that selective...
Yesterday, 11:22 AM Read Full Story -
A Research Roadmap of Open Problems in Biogerontology
Researchers here present a list of open problems...
Yesterday, 11:11 AM Read Full Story -
Fight Aging! Newsletter, November 17th 2025
Fight Aging! publishes news and commentary releva...
Nov 16 2025 11:31 AM Read Full Story -
Recombinant FGF19 as a Treatment to Increase Muscle Strength
A number of approaches to inducing muscle growth...
Nov 14 2025 07:51 PM Read Full Story
Elders Advice Video Prize
|
Submit a video interview with someone aged 78 or older and win a book, CD or video game of your choice from the LongeCity store. |
|
|
Entry conditions: 1- The person you are interviewing must be aged 78 or older. We are willing to trust you on this one, but we may ask for documentation if there is real doubt. 2- The interview should be between 8 and 10 minutes in length. |
![]() ![]() ![]() ![]() ![]() |
Email your submissions to support@imminst.org
Content Release Form
Questions? Ask in the forums




















0 Comments